Zobrazeno 1 - 1
of 1
pro vyhledávání: '"621"'
Autor:
David Nathanson, Klas Rikner, Thomas Nyström, Marcus Thuresson, Anna Norhammar, Johan Bodegard, Jan W. Eriksson
Publikováno v:
Diabetes, Obesity & Metabolism
Aims To investigate how the cardiovascular (CV) risk benefits of dapagliflozin translate into healthcare costs compared with other non‐sodium–glucose cotransporter‐2 inhibitor glucose‐lowering drugs (oGLDs) in a real‐world population with t